These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 34941564

  • 1. Single-dose pharmacokinetics of orally administered terbinafine in bearded dragons (Pogona vitticeps) and the antifungal susceptibility patterns of Nannizziopsis guarroi.
    McEntire MS, Reinhart JM, Cox SK, Keller KA.
    Am J Vet Res; 2021 Dec 22; 83(3):256-263. PubMed ID: 34941564
    [Abstract] [Full Text] [Related]

  • 2. Koch's postulates: Confirming Nannizziopsis guarroi as the cause of yellow fungal disease in Pogona vitticeps.
    Gentry SL, Lorch JM, Lankton JS, Pringle A.
    Mycologia; 2021 Dec 22; 113(6):1253-1263. PubMed ID: 34477498
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of subcutaneously administered hydromorphone in bearded dragons (Pogona vitticeps) and red-eared slider turtles (Trachemys scripta elegans).
    Hawkins SJ, Cox S, Yaw TJ, Sladky K.
    Vet Anaesth Analg; 2019 May 22; 46(3):352-359. PubMed ID: 30827804
    [Abstract] [Full Text] [Related]

  • 4. A Cross-Inoculation Experiment Reveals that Ophidiomyces ophiodiicola and Nannizziopsis guarroi Can Each Infect Both Snakes and Lizards.
    Gentry S, Lorch JM, Lankton JS, Pringle A.
    Appl Environ Microbiol; 2023 May 31; 89(5):e0216822. PubMed ID: 37098892
    [Abstract] [Full Text] [Related]

  • 5. Voriconazole, a safe alternative for treating infections caused by the Chrysosporium anamorph of Nannizziopsis vriesii in bearded dragons (Pogona vitticeps).
    Van Waeyenberghe L, Baert K, Pasmans F, van Rooij P, Hellebuyck T, Beernaert L, de Backer P, Haesebrouck F, Martel A.
    Med Mycol; 2010 Sep 31; 48(6):880-5. PubMed ID: 20370369
    [Abstract] [Full Text] [Related]

  • 6. Characterization of Nannizziopsis guarroi with genomic and proteomic analysis in three lizard species.
    Schneider J, Heydel T, Klasen L, Pees M, Schrödl W, Schmidt V.
    Med Mycol; 2018 Jul 01; 56(5):610-620. PubMed ID: 29420823
    [Abstract] [Full Text] [Related]

  • 7. Dermatomycosis in three central bearded dragons (Pogona vitticeps) associated with Nannizziopsis chlamydospora.
    Schmidt-Ukaj S, Loncaric I, Spergser J, Richter B, Hochleithner M.
    J Vet Diagn Invest; 2016 May 01; 28(3):319-22. PubMed ID: 26951329
    [Abstract] [Full Text] [Related]

  • 8. Nannizziopsis guarroi has prolonged environmental persistence on clinically relevant substrates.
    Keller KA, Durante K, Foltin E, Cerreta AJ.
    J Am Vet Med Assoc; 2023 Jun 01; 261(S1):S109-S113. PubMed ID: 36921022
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of subcutaneous versus intramuscular administration of ceftiofur crystalline-free acid to bearded dragons (Pogona vitticeps).
    Churgin SM, Musgrave KE, Cox SK, Sladky KK.
    Am J Vet Res; 2014 May 01; 75(5):453-9. PubMed ID: 24762017
    [Abstract] [Full Text] [Related]

  • 10. Infection with Devriesea agamarum and Chrysosporium guarroi in an inland bearded dragon (Pogona vitticeps).
    Schmidt-Ukaj S, Loncaric I, Klang A, Spergser J, Häbich AC, Knotek Z.
    Vet Dermatol; 2014 Dec 01; 25(6):555-8, e97. PubMed ID: 24963553
    [Abstract] [Full Text] [Related]

  • 11. Nannizziopsis guarroi infection in 2 Inland Bearded Dragons (Pogona vitticeps): clinical, cytologic, histologic, and ultrastructural aspects.
    Le Donne V, Crossland N, Brandão J, Sokolova Y, Fowlkes N, Nevarez JG, Langohr IM, Gaunt SD.
    Vet Clin Pathol; 2016 Jun 01; 45(2):368-375. PubMed ID: 27010762
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of subcutaneously administered electrolyte solutions in experimentally dehydrated inland bearded dragons (Pogona vitticeps).
    Parkinson LA, Mans C.
    Am J Vet Res; 2020 May 01; 81(5):437-441. PubMed ID: 32343174
    [Abstract] [Full Text] [Related]

  • 13. Deep fungal dermatitis in three inland bearded dragons (Pogona vitticeps) caused by the Chrysosporium anamorph of Nannizziopsis vriesii.
    Bowman MR, Paré JA, Sigler L, Naeser JP, Sladky KK, Hanley CS, Helmer P, Phillips LA, Brower A, Porter R.
    Med Mycol; 2007 Jun 01; 45(4):371-6. PubMed ID: 17510861
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics and pharmacodynamics of intramuscular alfaxalone in central bearded dragons (Pogona vitticeps): effect of injection site.
    Shippy S, Allgood H, Messenger K, Hernandez JA, Gatson B, Martin de Bustamante MG, Alexander AB, Wellehan JF, Johnson A.
    Vet Anaesth Analg; 2023 May 01; 50(3):280-288. PubMed ID: 36973133
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of furosemide administration to water-deprived inland bearded dragons (Pogona vitticeps).
    Parkinson LA, Mans C.
    Am J Vet Res; 2018 Nov 01; 79(11):1204-1208. PubMed ID: 30372154
    [Abstract] [Full Text] [Related]

  • 20. Intraerythrocytic iridovirus in central bearded dragons (Pogona vitticeps).
    Grosset C, Wellehan JF, Owens SD, McGraw S, Gaffney PM, Foley J, Childress AL, Yun S, Malm K, Groff JM, Paul-Murphy J, Weber ES.
    J Vet Diagn Invest; 2014 May 01; 26(3):354-364. PubMed ID: 24855223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.